Liquid Biopsy
News and reporting on cell-free DNA testing.
Guardant Health Reveal Assay Gets Additional Medicare Coverage for CRC Surveillance Testing
The test was previously covered for use in colorectal cancer patients in the early postsurgical setting only.
SeekIn's Two-Step Multi-Cancer Early Detection Method May Reduce False Positives, Screening Costs
Premium
Further screening individuals who test positive by SeekIn's OncoSeek protein biomarker test with the NGS-based SeekInCare assay reduced false positives in a study.
The retrospective results suggest that the test's sensitivity boost over other platforms can overcome the challenge of detecting ctDNA in adenocarcinomas.
Guardant Health, ConcertAI Partner on Combined Clinicogenomic Data-as-a-Service Offering
The companies aim to support novel drug development by providing biopharma researchers with longitudinal genomic test results paired with clinical EMR data.
Executives also provided additional information on the firm's Q4 2024 financial performance.